Alka-seltzer Extra Strength Granule, Effervescent
FDA Label NDC 0280-0211

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bayer Healthcare Llc. for the product Alka-seltzer Extra Strength (NDC 0280-0211). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding uses, warnings, do not use, ask a doctor before use if, stop use and ask a doctor if, directions, other information, inactive ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Directions

  • fully dissolve 2 tablets in 4 ounces of water before taking
  • adults and children 12 years and over2 tablets every 6 hours, or as directed by a doctordo not exceed 7 tablets in 24 hours
    adults 60 years and over2 tablets every 6 hours, or as directed by a doctordo not exceed 3 tablets in 24 hours
    children under 12 yearsconsult a doctor

Other Information

  • each tablet contains: sodium 588 mg
  • store at room temperature. Avoid excessive heat.
  • Alka-Seltzer Extra Strength in water contains principally the antacid sodium citrate and the analgesic sodium acetylsalicylate

Inactive Ingredients

flavor

* Please review the disclaimer below.